VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 63 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,660,299 | -53.2% | 177,193 | +22.4% | 0.00% | -50.0% |
| Q2 2023 | $3,551,159 | -9.7% | 144,768 | -14.3% | 0.00% | 0.0% |
| Q1 2023 | $3,931,979 | +23.4% | 168,972 | +34.2% | 0.00% | +33.3% |
| Q4 2022 | $3,187,491 | +89.6% | 125,938 | +44.4% | 0.00% | +50.0% |
| Q3 2022 | $1,681,000 | +6.6% | 87,198 | +40.8% | 0.00% | 0.0% |
| Q2 2022 | $1,577,000 | +14.5% | 61,936 | +15.7% | 0.00% | +100.0% |
| Q1 2022 | $1,377,000 | -42.4% | 53,527 | -6.4% | 0.00% | 0.0% |
| Q4 2021 | $2,392,000 | +7.1% | 57,157 | +11.4% | 0.00% | 0.0% |
| Q3 2021 | $2,233,000 | -18.8% | 51,322 | -11.8% | 0.00% | 0.0% |
| Q2 2021 | $2,751,000 | +407.6% | 58,173 | +450.2% | 0.00% | – |
| Q1 2021 | $542,000 | -67.3% | 10,573 | -82.9% | 0.00% | -100.0% |
| Q4 2020 | $1,655,000 | +595.4% | 61,836 | +965.4% | 0.00% | – |
| Q2 2020 | $238,000 | -16.5% | 5,804 | -30.2% | 0.00% | – |
| Q1 2020 | $285,000 | – | 8,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |